Restoring the mass of beta cells, or insulin-producing cells, in diabetics could cure these patients of their disease. Four potential ways to do this include transplanting donor cadaveric beta cells, inducing progenitor cells in the pancreas to produce new beta cells, and generating beta cells.
Dr. Gannon received her B.S. in biology from Molloy College and her M.S. in biology from Adelphi University, both on Long Island. Her thesis work was conducted in Dr. David Bader’s lab at Cornell University, where she received her Ph.D. in cell biology and anatomy in 1995. Dr. Gannon pursued postdoctoral training in Dr. Chris Wright’s laboratory at Vanderbilt University, studying the role of the Pdx1 and HNF6 transcription factors in pancreas development. She is currently Professor and Vice Chair for Faculty Development in the Department of Medicine at Vanderbilt University Medical Center. Dr. Gannon is also the 2017–2018 chair of the American Diabetes Association (ADA) science session planning committee. She was elected an American Association for the Advancement of Science (AAAS) fellow in 2015, and she has received funding from JDRF, the National Institutes of Health (NIH), ADA, and the U.S. Department of Veterans Affairs (VA).